Business & regional news

Month Year

Month Year

Nov 28, 2023

First patient treated with Medtronic Symplicity Spyral™ renal denervation system at Piedmont
- Cardiovascular Diagnostics and Services
- Coronary and Renal Denervation
Sep 21, 2022

Medtronic is the first and only company to receive FDA indication for bifurcation percutaneous coronary intervention with a drug-eluting stent

Bifurcation using Onyx Frontier DES Medtronic announced today that it has received Food and Drug Administration (FDA) approval for the treatment of non-left main bifurcation lesions utilizing the...
- Coronary and Renal Denervation
Aug 24, 2022

Medtronic launches latest generation drug-eluting coronary stent system following CE Mark approval

Medtronic announced today that it has launched its newest drug-eluting coronary stent, the Onyx Frontier™ drug-eluting stent (DES), following recent CE Mark approval. The Onyx Frontier DES...
- Coronary and Renal Denervation

Show per page